This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
GlaxoSmithKline (GSK.L) – It is to pay an initial $317m to buy the late stage HIV research assets and $33m for the preclinical and discovery stage assets, with both deals subject to further payments of over $500m dependent on commercial milestones. Closing Price 1341.50p (Reuters)
Standard Chartered (STAN.L) - May attract takeover offers should it struggle to turn itself around, CLSA Ltd. said. The most likely acquirer for the London-based lender is Singapore’s DBS Group Holdings Ltd., which would be able to bolster its presence in cities such as Hong Kong and Singapore, and gain access to markets in Southeast Asia. Closing Price 549.90p (Bloomberg)
Barclays (BARC.L) - The UK bank's Asian private wealth business also seen as a potential target for DBS Group Holdings. Closing Price 218.85p. (Reuters)
BHP Billiton (BLT) - Moody's has placed the miner on its downgrade watch list. Closing Price 700p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Standard Chartered | STAN | 7.26% | 9.13% | 2.44% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research